0001104659-20-120937.txt : 20201103 0001104659-20-120937.hdr.sgml : 20201103 20201103160746 ACCESSION NUMBER: 0001104659-20-120937 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201102 FILED AS OF DATE: 20201103 DATE AS OF CHANGE: 20201103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lewis Tanya CENTRAL INDEX KEY: 0001451038 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38596 FILM NUMBER: 201283560 MAIL ADDRESS: STREET 1: C/O KARYOPHARM THERAPEUTICS INC. STREET 2: 85 WELLS AVE. CITY: NEWTON STATE: MA ZIP: 02459 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Replimune Group, Inc. CENTRAL INDEX KEY: 0001737953 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 822082553 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: (781) 222-9600 MAIL ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 4 1 a4.xml 4 X0306 4 2020-11-02 0 0001737953 Replimune Group, Inc. REPL 0001451038 Lewis Tanya C/O REPLIMUNE GROUP, INC. 500 UNICORN PARK DRIVE WOBURN MA 01801 1 0 0 0 Stock Option (right to buy) 42.00 2020-11-02 4 A 0 33000 0 A 2030-11-02 Common Stock 33000 33000 D 25% of the shares underlying this stock option vest on November 2, 2021, and the remainder of the shares underlying this stock option vest in 24 approximately equal monthly installments thereafter. /s/ Jean Franchi, attorney-in-fact 2020-11-02